Injectable medication for the treatment and management of HIV has been granted regulatory approval by the European Medicines Agency (EMA).
Vocabria (cabotegravir) has been hailed as a breakthrough in HIV treatment because it can be offered as monthly or bi-monthly injections.
Currently most meds regimes for HIV require daily pills and the golden rule for the regimes is adherence: consistent doses at consistent times.“Daily antiretrovirals have transformed the lives of people living with HIV,” Dr.
Antonio Antela of the University Hospital in Santiago de Compostela, Spain who helped administer the trials. “However, taking daily medication can pose challenges for some people; it may act as a constant reminder of HIV or be a cause of fear that.